• 17542 Citations
  • 65 h-Index
1978 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Interleukin-6 Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Genes Medicine & Life Sciences
Interleukin-6 Receptors Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
DNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

  • 17542 Citations
  • 65 h-Index
  • 344 Article
  • 9 Review article
  • 2 Chapter
  • 1 Comment/debate

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D’Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 othersFabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Feb 1 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

Research output: Contribution to journalArticle

The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma

Fattore, L., Mancini, R., Ascierto, P. A. & Ciliberto, G., Jan 2 2019, In : Expert Opinion on Therapeutic Targets. 23, 1, p. 53-68 16 p.

Research output: Contribution to journalArticle

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D'Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 othersFabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Nov 7 2018, In : Cancer Biology and Therapy. p. 1-9 9 p.

Research output: Contribution to journalArticle

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients

Palermo, B., Franzese, O., Donna, C. D., Panetta, M., Quintarelli, C., Sperduti, I., Gualtieri, N., Foddai, M. L., Proietti, E., Ferraresi, V., Ciliberto, G. & Nisticò, P., Dec 2 2018, In : OncoImmunology. 7, 12, p. e1465163

Research output: Contribution to journalArticle

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients

Palermo, B., Franzese, O., Donna, C. D., Panetta, M., Quintarelli, C., Sperduti, I., Gualtieri, N., Foddai, M. L., Proietti, E., Ferraresi, V., Ciliberto, G. & Nisticò, P., Sep 11 2018, In : OncoImmunology. 7, 12, p. e1465163 13 p.

Research output: Contribution to journalArticle

Dacarbazine
Melanoma
Vaccination
T-Lymphocytes
MART-1 Antigen